SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
Without enough B12, these cells can become large and misshapen (megaloblastic anaemia), reducing oxygen flow to your brain and muscles, causing fatigue and weakness
If a rash, hives, swelling, or trouble breathing shows up, stop use immediately and seek medical care
Lebers Disease: People with Lebers disease, a rare inherited eye condition, should avoid vitamin B12 injections
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial
Hence they look and feel a whole lot better